The Combination of circEPSTI1 and MIF Offers Diagnostic Value for Endometrial Cancer

References

• Neacsu A, Marcu ML, Stanica CD, et al. Clinical and morphological correlations in early diagnosis of endometrial cancer. Rom J Morphol Embryol. 2018;59(2):527–531.
   PubMed Web of Science ®Google Scholar
• Tarney CM, Wang G, Bateman NW, et al. Biomarker panel for early detection of endometrial cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Obstet Gynecol. 2019;221(5):472 e471–472 e410. doi:10.1016/j.ajog.2019.06.005
   Web of Science ®Google Scholar
• Gottwald L, Kubiak R, Pasz-Walczak G, et al. The value of progesterone and estrogen receptors expression in tissue microarray method in prognosis of patients with endometrioid endometrial cancer. Ginekol Pol. 2013;84(2):95–101. doi:10.17772/gp/1602
   PubMed Web of Science ®Google Scholar
• Panda AC, Grammatikakis I, Munk R, Gorospe M, Abdelmohsen K. Emerging roles and context of circular RNAs. Wiley Interdiscip Rev RNA. 2017;8(2). doi:10.1002/wrna.1386
   PubMed Web of Science ®Google Scholar
• Muller S, Appel B. In vitro circularization of RNA. RNA Biol. 2017;14(8):1018–1027. doi:10.1080/15476286.2016.1239009
   PubMed Web of Science ®Google Scholar
• Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: identification, biogenesis and function. Biochim Biophys Acta. 2016;1859(1):163–168. doi:10.1016/j.bbagrm.2015.07.007
   PubMed Web of Science ®Google Scholar
• Chen RX, Liu HL, Yang LL, et al. Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. Eur Rev Med Pharmacol Sci. 2019;23(20):8771–8778.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang J, Wang C, Liu M, Zou Q. Deep learning models for disease-associated circRNA prediction: a review. Brief Bioinform. 2022;23(6). doi:10.1093/bib/bbac364
   Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7. doi:10.1007/s12282-017-0793-9
   PubMed Web of Science ®Google Scholar
• Jiang B, Zhang J, Sun X, et al. Circulating exosomal hsa_circRNA_0039480 is highly expressed in gestational diabetes mellitus and may be served as a biomarker for early diagnosis of GDM. J Transl Med. 2022;20(1):5. doi:10.1186/s12967-021-03195-5
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen S, Zong ZH, Guan X, Zhao Y. CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer. J Cell Mol Med. 2020;24(12):6898–6907. doi:10.1111/jcmm.15346
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen S, Wei S, et al. CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer. Redox Biol. 2022;57:102493. doi:10.1016/j.redox.2022.102493
   PubMed Web of Science ®Google Scholar
• Wu P, Li C, Ye DM, et al. Circular RNA circEPSTI1 accelerates cervical cancer progression via miR-375/409-3P/515-5p-SLC7A11 axis. Aging. 2021;13(3):4663–4673. doi:10.18632/aging.202518
   PubMedGoogle Scholar
• Wang J, Jiang C, Li N, et al. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway. Cell Death Dis. 2020;11(8):682. doi:10.1038/s41419-020-02851-w
   PubMed Web of Science ®Google Scholar
• Xie J, Wang S, Li G, et al. circEPSTI1 regulates ovarian cancer progression via decoying miR-942. J Cell Mol Med. 2019;23(5):3597–3602. doi:10.1111/jcmm.14260
   PubMed Web of Science ®Google Scholar
• Xie Y, Wang L, Yang D. CircEPSTI1 promotes the progression of non-small cell lung cancer through miR-145/HMGB3 Axis. Cancer Manag Res. 2020;12:6827–6836. doi:10.2147/CMAR.S252893
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tan D, Xie Y, et al. CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis. J Oncol. 2022;2022:1028851. doi:10.1155/2022/1028851
   PubMed Web of Science ®Google Scholar
• Xiao W, Dong X, Zhao H, et al. Expression of MIF and c-erbB-2 in endometrial cancer. Mol Med Rep. 2016;13(5):3828–3834. doi:10.3892/mmr.2016.4992
   PubMed Web of Science ®Google Scholar
• Mizue Y, Ghani S, Leng L, et al. Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A. 2005;102(40):14410–14415. doi:10.1073/pnas.0507189102
   PubMed Web of Science ®Google Scholar
• Bucala R, Donnelly SC. Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity. 2007;26(3):281–285. doi:10.1016/j.immuni.2007.03.005
   PubMed Web of Science ®Google Scholar
• Ma Y, Li Z, Ma D, Guo J, Sun W. Hsa_circ_0003195 as a biomarker for diagnosis and prognosis of gastric cancer. Int J Clin Oncol. 2022;27(2):354–361. doi:10.1007/s10147-021-02073-w
   PubMed Web of Science ®Google Scholar
• Lei B, Tian Z, Fan W, Ni B. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci. 2019;16(2):292–301. doi:10.7150/ijms.28047
   PubMed Web of Science ®Google Scholar
• Vea A, Llorente-Cortes V, de Gonzalo-Calvo D. Circular RNAs in Blood. Adv Exp Med Biol. 2018;1087:119–130.
   PubMed Web of Science ®Google Scholar
• Guo S, Hu C, Zhai X, Sun D. Circular RNA 0006602 in plasma exosomes: a new potential diagnostic biomarker for hepatocellular carcinoma. Am J Transl Res. 2021;13(6):6001–6015.
   PubMed Web of Science ®Google Scholar
• Omid-Shafaat R, Moayeri H, Rahimi K, et al. Serum Circ-FAF1/Circ-ELP3: a novel potential biomarker for breast cancer diagnosis. J Clin Lab Anal. 2021;35(11):e24008. doi:10.1002/jcla.24008
   PubMed Web of Science ®Google Scholar
• Shen X, Kong S, Ma S, et al. Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis. Oncogene. 2022;41(42):4724–4735. doi:10.1038/s41388-022-02449-w
   PubMed Web of Science ®Google Scholar
• Yuan W, Fang R, Mao C, Chen H, Tai B, Cong H. Serum circular RNA hsa_circ_0000702 as a novel biomarker for diagnosis of gastric cancer. J Clin Lab Anal. 2023;37(3):e24842. doi:10.1002/jcla.24842
   PubMed Web of Science ®Google Scholar
• Hagemann T, Robinson SC, Thompson RG, Charles K, Kulbe H, Balkwill FR. Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol Cancer Ther. 2007;6(7):1993–2002. doi:10.1158/1535-7163.MCT-07-0118
   PubMed Web of Science ®Google Scholar
• Nishihira J, Ishibashi T, Fukushima T, Sun B, Sato Y, Todo S. Macrophage migration inhibitory factor (MIF): its potential role in tumor growth and tumor-associated angiogenesis. Ann N Y Acad Sci. 2003;995(1):171–182. doi:10.1111/j.1749-6632.2003.tb03220.x
   PubMedGoogle Scholar